Aya Kobayashi

3.6k total citations · 1 hit paper
46 papers, 2.5k citations indexed

About

Aya Kobayashi is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Aya Kobayashi has authored 46 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Aya Kobayashi's work include Drug Transport and Resistance Mechanisms (7 papers), Cholesterol and Lipid Metabolism (6 papers) and Mechanisms of cancer metastasis (5 papers). Aya Kobayashi is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Cholesterol and Lipid Metabolism (6 papers) and Mechanisms of cancer metastasis (5 papers). Aya Kobayashi collaborates with scholars based in Japan and United States. Aya Kobayashi's co-authors include Kounosuke Watabe, Hiroshi Okuda, Misako Watabe, Sudha K. Pai, Fei Xing, Shigeru Hirota, Puspa R. Pandey, Eiji Furuta, Koji Fukuda and Michinori Matsuo and has published in prestigious journals such as Science, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Aya Kobayashi

44 papers receiving 2.5k citations

Hit Papers

A major chromatin regulator determines resistance of tumo... 2018 2026 2020 2023 2018 100 200 300 400 500

Peers

Aya Kobayashi
Joseph Kwong Hong Kong
Verena Tischler Switzerland
R.R. Weichselbaum United States
Zhenhe Suo Norway
Anushka Dongre United States
Aya Kobayashi
Citations per year, relative to Aya Kobayashi Aya Kobayashi (= 1×) peers Yoshitaka Hippo

Countries citing papers authored by Aya Kobayashi

Since Specialization
Citations

This map shows the geographic impact of Aya Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aya Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aya Kobayashi more than expected).

Fields of papers citing papers by Aya Kobayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aya Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aya Kobayashi. The network helps show where Aya Kobayashi may publish in the future.

Co-authorship network of co-authors of Aya Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Aya Kobayashi. A scholar is included among the top collaborators of Aya Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aya Kobayashi. Aya Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nobili, Alberto, Aya Kobayashi, Patrick C. Gedeon, & Carl D. Novina. (2022). Clutch Control: Changing the Speed and Direction of CAR-T Cell Therapy. PubMed. 4(2). 52–59.
2.
Kobayashi, Aya, et al.. (2022). Light‐Controllable Binary Switch Activation of CAR T Cells. ChemMedChem. 17(12). e202100722–e202100722. 14 indexed citations
3.
Pan, Deng, Aya Kobayashi, Peng Jiang, et al.. (2018). A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing. Science. 359(6377). 770–775. 567 indexed citations breakdown →
4.
Kobayashi, Aya, et al.. (2017). Rapidly progressing large-cell neuroendocrine carcinoma arising from the uterine corpus: A case report and review of the literature. Molecular and Clinical Oncology. 6(6). 881–885. 16 indexed citations
5.
Sano, Osamu, Maki Tsujita, Yūji Shimizu, et al.. (2016). ABCG1 and ABCG4 Suppress γ-Secretase Activity and Amyloid β Production. PLoS ONE. 11(5). e0155400–e0155400. 39 indexed citations
6.
Kobayashi, Aya, Akihiko Kimura, Yuko Ishida, et al.. (2015). AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer. European Journal of Pharmacology. 766. 63–75. 21 indexed citations
7.
Mabuchi, Yasushi, et al.. (2015). Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB. International Journal of Gynecological Cancer. 25(9). 1677–1682. 14 indexed citations
8.
Xing, Fei, Aya Kobayashi, Hiroshi Okuda, et al.. (2013). Reactive astrocytes promote the metastatic growth of breast cancer stem‐like cells by activating Notch signalling in brain. EMBO Molecular Medicine. 5(3). 384–396. 146 indexed citations
9.
Liu, Wen, Fei Xing, Hiroshi Okuda, et al.. (2012). N‐myc downstream regulated gene 1 modulates Wnt‐β‐catenin signalling and pleiotropically suppresses metastasis. EMBO Molecular Medicine. 4(2). 93–108. 173 indexed citations
10.
Kobayashi, Aya, Hiroshi Okuda, Fei Xing, et al.. (2012). Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. The Journal of Experimental Medicine. 209(3). 639–639. 11 indexed citations
11.
Tanaka, Tetsuji, Tao Bai, Saori Toujima, et al.. (2012). Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells. Oncology Reports. 27(4). 1292–1298. 7 indexed citations
12.
Okuda, Hiroshi, Aya Kobayashi, Bo Xia, et al.. (2011). Hyaluronan Synthase HAS2 Promotes Tumor Progression in Bone by Stimulating the Interaction of Breast Cancer Stem–Like Cells with Macrophages and Stromal Cells. Cancer Research. 72(2). 537–547. 160 indexed citations
13.
Muragaki, Yasuteru, et al.. (2011). Immunohistochemical analysis of collagen expression in uterine leiomyomata during the menstrual cycle. Experimental and Therapeutic Medicine. 2(2). 287–290. 10 indexed citations
14.
Liu, Wen, Eiji Furuta, Kazutoshi Shindo, et al.. (2010). Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway. Breast Cancer Research and Treatment. 128(1). 57–68. 29 indexed citations
15.
Hirata, Takashi, et al.. (2009). Molecular Mechanisms of Subcellular Localization of ABCG5 and ABCG8. Bioscience Biotechnology and Biochemistry. 73(3). 619–626. 28 indexed citations
16.
Iiizumi, Megumi, Sucharita Bandyopadhyay, Sudha K. Pai, et al.. (2008). RhoC Promotes Metastasis via Activation of the Pyk2 Pathway in Prostate Cancer. Cancer Research. 68(18). 7613–7620. 85 indexed citations
17.
Sano, Osamu, Aya Kobayashi, Kohjiro Nagao, et al.. (2007). Sphingomyelin-dependence of cholesterol efflux mediated by ABCG1. Journal of Lipid Research. 48(11). 2377–2384. 59 indexed citations
18.
Nakajima, Hiroo, Naruhiko Mizuta, Katsuhiko Nakatsukasa, et al.. (2006). [A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].. PubMed. 33(9). 1305–8. 1 indexed citations
19.
Kobayashi, Aya, Yasukazu Takanezawa, Takashi Hirata, et al.. (2006). Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. Journal of Lipid Research. 47(8). 1791–1802. 166 indexed citations
20.
Hamada, Hiroshi, et al.. (1995). Prophylactic hemostatic drugs do not reduce hemorrhage: Thromboelastographic study during upper abdominal surgery. Journal of Anesthesia. 9(1). 32–35. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026